Active ingredient
- metaraminol tartrate
Legal Category
POM: Prescription only medicine
POM: Prescription only medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL13079/0011 .
Metaraminol 10mg/mL Solution for Injection or Infusion
Package Leaflet: Information for the user
Metaraminol 10mg/mL Solution for Injection or Infusion
Metaraminol Tartrate
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
What is in this leaflet:
1. What Metaraminol 10mg/mL Solution for Injection or Infusion is and what it is used for
2. What you need to know before you use Metaraminol 10mg/mL Solution for Injection or Infusion
3. How to use Metaraminol 10mg/mL Solution for Injection or Infusion
4. Possible Side Effects
5. How to store Metaraminol 10mg/mL Solution for Injection or Infusion
6. Contents of the pack and other information
1. What Metaraminol 10mg/mL Solution for Injection or Infusion is and what it is used for
The active substance Metaraminol Tartrate belongs to a group of medicines called vasopressors which work by narrowing the blood vessels causing blood pressure to rise.
It is used to:
2. What you need to know before you use Metaraminol 10mg/mL Solution for Injection or Infusion
You will be given this medicine in hospital by a doctor or nurse.
Do not use this medicine:
Warnings and Precautions
Talk to your doctor, nurse of pharmacist before using Metaraminol 10mg/mL Solution for Injection or Infusion if you have:
Children
Do not use this medicine in children below the age of 12 years.
Other Medicines and Metaraminol 10mg/mL Solution for Injection or Infusion
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. It is especially important if you are taking:
Pregnancy, breast-feeding and fertility
The effects of this medicine on fertility and the unborn baby are unknown. It is not known whether this medicine is present in breast milk. You will only be given this medicine if your doctor sees the clinical need to do so in an emergency situation.
Metaraminol 10mg/mL Solution for Injection or Infusion contains Sodium Metabisulfite and Sodium Chloride
This medicine contains
3. How to use Metaraminol 10mg/mL Solution for Injection or Infusion
A nurse or doctor will give you this medicine.
The recommended dose is:
In the case of an emergency this medicine is given by direct injection into a vein, followed by an infusion into a vein. The dose will be adjusted by your doctor, but the usual dose is between 0.5mg and 5mg injected into the vein, followed by an infusion of 15 - 100 mg in 500 mL Sodium Chloride Injection or Dextrose 5% Injection.
If you are given more Metaraminol 10mg/mL Solution for Injection or Infusion than you should
It is unlikely that you will receive too much because this medicine will be given to you in hospital. You will be carefully monitored by your doctor for symptoms or severely high blood pressure (see symptoms in Section 4 Possible Side Effects).
4. Possible Side Effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor immediately if you experience:
The following symptoms may be due to severely high blood pressure. Tell your doctor immediately if you experience:
Tell your doctor as soon as possible if you experience:
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: Website: www.mhra.gov.uk/yellowcard or Search for MHRA Yellow Card in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store Metaraminol 10mg/mL Solution for Injection or Infusion
6. Contents of the pack and other information
What Metaraminol 10mg/mL Solution for Injection or Infusion contains
The active substance is Metaraminol Tartrate (1.9% w/v), which is equivalent to 1% w/v (10mg/mL) Metaraminol.
The other ingredients are: Sodium Chloride, Sodium Metabisulfite (E223) and Water for Injections.
What Metaraminol 10mg/mL Solution for Injection or Infusion looks like and contents of the pack:
This medicine is a clear, colourless solution in a 1 mL glass ampoule. This medicine is packed into cartons containing 10 ampoules.
Marketing Authorisation Holder and Manufacturer:
This leaflet was last revised in: 08/2018
PL 13079/0011
PIL/11/4
Wilkins Drive, Paignton, TQ4 7FG
+44 (0)1803 660000
+44 (0)7824 889143
+44 (0)1803 664707
+44 (0)1803 664707
+44 (0)1803 664354
+44 (0)1803 664 354